Resveratrol ameliorates experimental autoimmune myocarditis

被引:66
|
作者
Yoshida, Yuki [1 ]
Shioi, Tetsuo [1 ]
Izumi, Tohru [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Internal Med & Cardiol, Sagamihara, Kanagawa 228, Japan
关键词
aging; heart failure; myocarditis; resveratrol;
D O I
10.1253/circj.71.397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Myosin-induced autoimmune myocarditis of rats is a model of human dilated cardiomyopathy. Resveratrol is a natural polyphenol found in grapes and wine that is reported to have cardioprotective and immunomodulatory effects. Methods and Results To examine the effect of resveratrol on myocarditis, vehicle or resveratrol (50mg/kg per day) was administered to cardiac myosin immunized rats I day before the immunization. At 14 days after immunization, resveratrol had preserved cardiac function of myosin-immunized rats according to echocardiographic analysis. The heart weight/tibial length ratio of vehicle-treated myosin-immunized rats was increased by 1.8-fold compared with unimmunized rats, and resveratrol attenuated the heart weight increase. Resveratrol significantly decreased cellular infiltration, fibrosis, and expression of inflammatory cytokines in the myocardium. Expressions of antioxidant genes were increased in myosin-immunized hearts, and resveratrol decreased those expressions. Resveratrol also attenuated myocarditis 21 days after immunization. SIRT1, a potential effector of resveratrol, was increased in the myocardium of myosin-immunized rats compared with unimmunized rats. The SIRT1 protein was localized mainly in infiltrating mononuclear cells. Conclusions Resveratrol significantly ameliorated myocardial injury and preserved cardiac function in a rat model of autoimmune myocarditis. Resveratrol may be a therapeutic modality for myocarditis.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 50 条
  • [11] Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis
    Shiheido-Watanabe, Yuka
    Maejima, Yasuhiro
    Kasama, Takeshi
    Tamura, Natsuko
    Nakagama, Shun
    Ito, Yusuke
    Hirao, Kenzo
    Isobe, Mitsuaki
    Sasano, Tetsuo
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2021, 6 (06): : 527 - 542
  • [12] Mononuclear cell secretome protects from experimental autoimmune myocarditis
    Hoetzenecker, Konrad
    Zimmermann, Matthias
    Hoetzenecker, Wolfram
    Schweiger, Thomas
    Kollmann, Dagmar
    Mildner, Michael
    Hegedus, Balazs
    Mitterbauer, Andreas
    Hacker, Stefan
    Birner, Peter
    Gabriel, Christian
    Gyoengyoesi, Mariann
    Blyszczuk, Przemyslaw
    Eriksson, Urs
    Ankersmit, Hendrik Jan
    EUROPEAN HEART JOURNAL, 2015, 36 (11) : 676 - +
  • [13] Blocking VCAM-1/VLA-4 Axis Ameliorates Inflammation and Fibrosis in Experimental Autoimmune Myocarditis
    Grabmaier, Ulrich
    Brunner, Stefan
    Grabmeier, Johanna
    Kania, Gabriela
    Eriksson, Urs
    Herbach, Nadia
    Wanke, Rudiger
    Franz, Wolfgang-Michael
    CIRCULATION, 2012, 126 (21)
  • [14] L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes
    Okabe, Taka-aki
    Hattori, Miki
    Yuan, Zuyi
    Kishimoto, Chiharu
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2008, 89 (05) : 382 - 388
  • [15] Amiodarone minimizes experimental autoimmune myocarditis in rats
    Matsui, S
    Zong, ZP
    Han, JF
    Katsuda, S
    Yamaguchi, N
    Fu, MLX
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 469 (1-3) : 165 - 173
  • [16] Captopril ameliorates myocarditis in acute experimental Chagas disease
    Leon, JS
    Wang, KG
    Engman, DM
    CIRCULATION, 2003, 107 (17) : 2264 - 2269
  • [17] Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis - A potential role for induction of T helper 2 cytokines
    Futamatsu, H
    Suzuki, J
    Mizuno, S
    Koga, N
    Adachi, S
    Kosuge, H
    Maejima, Y
    Hirao, K
    Nakamura, T
    Isobe, M
    CIRCULATION RESEARCH, 2005, 96 (08) : 823 - 830
  • [18] Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
    Mueller, Anna-Maria
    Fischer, Andrea
    Katus, Hugo A.
    Kaya, Ziya
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2498 - 2512
  • [19] Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression
    Yuan, Z
    Kishimoto, C
    Shioji, K
    Nakamura, H
    Yodoi, J
    Sasayama, S
    CARDIOVASCULAR RESEARCH, 2002, 55 (02) : 320 - 328
  • [20] Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression
    Zuyi Yuan
    Chiharu Kishimoto
    Keisuke Shioji
    Hajime Nakamura
    Junji Yodoi
    Shigekake Sasayama
    Molecular and Cellular Biochemistry, 2003, 248 : 185 - 192